X-15479812-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000380420.10(PIR):c.106C>A(p.Leu36Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,128,400 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 90 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000098 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.00014 ( 0 hom. 85 hem. )
Consequence
PIR
ENST00000380420.10 missense
ENST00000380420.10 missense
Scores
1
7
9
Clinical Significance
Conservation
PhyloP100: 1.55
Genes affected
PIR (HGNC:30048): (pirin) This gene encodes a member of the cupin superfamily. The encoded protein is an Fe(II)-containing nuclear protein expressed in all tissues of the body and concentrated within dot-like subnuclear structures. Interactions with nuclear factor I/CCAAT box transcription factor as well as B cell lymphoma 3-encoded oncoprotein suggest the encoded protein may act as a transcriptional cofactor and be involved in the regulation of DNA transcription and replication. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
BMX (HGNC:1079): (BMX non-receptor tyrosine kinase) This gene encodes a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.01931864).
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIR | NM_001018109.3 | c.106C>A | p.Leu36Met | missense_variant | 3/10 | ENST00000380420.10 | NP_001018119.1 | |
PIR-FIGF | NR_037859.2 | n.158C>A | non_coding_transcript_exon_variant | 2/15 | ||||
PIR | NM_003662.4 | c.106C>A | p.Leu36Met | missense_variant | 3/10 | NP_003653.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIR | ENST00000380420.10 | c.106C>A | p.Leu36Met | missense_variant | 3/10 | 1 | NM_001018109.3 | ENSP00000369785 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000983 AC: 11AN: 111871Hom.: 0 Cov.: 23 AF XY: 0.000147 AC XY: 5AN XY: 34053
GnomAD3 genomes
AF:
AC:
11
AN:
111871
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
34053
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000201 AC: 33AN: 164133Hom.: 0 AF XY: 0.000423 AC XY: 22AN XY: 52027
GnomAD3 exomes
AF:
AC:
33
AN:
164133
Hom.:
AF XY:
AC XY:
22
AN XY:
52027
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000145 AC: 147AN: 1016475Hom.: 0 Cov.: 19 AF XY: 0.000286 AC XY: 85AN XY: 297433
GnomAD4 exome
AF:
AC:
147
AN:
1016475
Hom.:
Cov.:
19
AF XY:
AC XY:
85
AN XY:
297433
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000983 AC: 11AN: 111925Hom.: 0 Cov.: 23 AF XY: 0.000147 AC XY: 5AN XY: 34117
GnomAD4 genome
AF:
AC:
11
AN:
111925
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
34117
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
50
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.106C>A (p.L36M) alteration is located in exon 3 (coding exon 2) of the PIR gene. This alteration results from a C to A substitution at nucleotide position 106, causing the leucine (L) at amino acid position 36 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Gain of ubiquitination at K34 (P = 0.046);Gain of ubiquitination at K34 (P = 0.046);
MVP
MPC
0.20
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at